PatientsVille.com Logo

PatientsVille

Daptomycin Side Effects

Report Daptomycin Side Effects

If you experienced any harmful or unwanted effects of Daptomycin, please share your experience. This could help to raise awareness about Daptomycin side effects, identify uknown risks and inform health professionals and patients taking Daptomycin.

Examples: headache, dizziness


The most commonly reported Daptomycin side effects are:
Hair Loss (2 reports)
Palpitation (2 reports)
Blurred Vision In Left Eye Only (1 reports)
Fast Heartbeat (1 reports)
Fatigue (1 reports)
Incontenencia Fecal (1 reports)
Joint Pain In Fingers Hands (1 reports)
Vancomycin (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.


To view a complete list of submitted side effects, please follow the link Daptomycin side effects . You can also compare Daptomycin side effects or view FDA reports.

Daptomycin Side Effects reported to FDA

The following Daptomycin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Daptomycin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 11 

Renal Failure
on Aug 12, 2013 Female from US , 47 years of age, weighting 259.9 lb, was diagnosed with and was treated with Daptomycin. Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: renal failure. Daptomycin dosage: 1750 Mg, Q12h.
Associated medications used:
  • Unasyn /00903601/ (3 G, Q6h)
  • Cleocin /00166002/ (600 Mg, Q6h)
  • Cleocin /00166002/ (600 Mg, Q6h)


Rash
Patient was taking Daptomycin. Patient felt the following Daptomycin side effects: rash on Aug 11, 2013 from US Additional patient health information: Female , 37 years of age, weighting 187.4 lb, was diagnosed with and. Daptomycin dosage: 500 Mg, Q24h.

Chest Pain, Musculoskeletal Pain, Blood Creatine Phosphokinase Increased, Myalgia
Adverse event was reported on Aug 01, 2013 by a Male taking Daptomycin (Dosage: N/A) was diagnosed with and. Location: US , weighting 224.0 lb, After Daptomycin was administered, patient encountered several Daptomycin side effects: chest pain, musculoskeletal pain, blood creatine phosphokinase increased, myalgia. Patient was hospitalized.

Eosinophilic Pneumonia
on Jul 19, 2013 Male from US , 86 years of age, weighting 209.4 lb, was diagnosed with and was treated with Daptomycin (cubicin). Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: eosinophilic pneumonia. Daptomycin (cubicin) dosage: Q48h.


Blood Creatine Phosphokinase Increased, Muscular Weakness, Myalgia
on Jul 09, 2013 Female from US , 45 years of age, weighting 204.6 lb, was diagnosed with and was treated with Daptomycin. Patient felt the following Daptomycin side effects: blood creatine phosphokinase increased, muscular weakness, myalgia. Daptomycin dosage: Every 24 Hours.
Multiple prescriptions taken:

Interstitial Lung Disease
Patient was taking Daptomycin. After Daptomycin was administered, patient encountered several Daptomycin side effects: interstitial lung disease on Jul 01, 2013 from US Additional patient health information: Male , 61 years of age, weighting 224.9 lb, was diagnosed with and. Daptomycin dosage: 600 Mg Ud Iv.

Leukopenia, Neutropenia
Adverse event was reported on Jun 13, 2013 by a Male taking Daptomycin (Dosage: 350 Mg Every Day Iv) was diagnosed with and. Location: US , 89 years of age, weighting 128.3 lb, Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: leukopenia, neutropenia.

Nausea, Asthenia, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cholelithiasis
on May 14, 2013 Female from US , 68 years of age, was diagnosed with and was treated with Daptomycin. Patient felt the following Daptomycin side effects: nausea, asthenia, alanine aminotransferase increased, aspartate aminotransferase increased, cholelithiasis. Daptomycin dosage: N/A.
Multiple prescriptions taken:

Eosinophilic Pneumonia
on Apr 19, 2013 Male from US , 48 years of age, weighting 321.0 lb, was diagnosed with and was treated with Daptomycin. After Daptomycin was administered, patient encountered several Daptomycin side effects: eosinophilic pneumonia. Daptomycin dosage: N/A.
Multiple concurrent drugs taken:
  • Oxycodone/apap
  • Alprazolam
  • Methadone
  • Pantoprazole
  • Metoprolol Tartrate
  • Testosterone Gel
  • Nifedipine Er
  • Sertraline
Patient was hospitalized.

Eosinophilic Pneumonia Acute, Sepsis, Renal Disorder, International Normalised Ratio Increased
Patient was taking Daptomycin. Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: eosinophilic pneumonia acute, sepsis, renal disorder, international normalised ratio increased on Apr 10, 2013 from US Additional patient health information: Male , 34 years of age, weighting 287.7 lb, was diagnosed with and. Daptomycin dosage: Recent.
Associated medications used:
  • Coumadin (Chronic Mtwthsat)
  • Paxil
  • Lopressor
  • Oxycontin
  • Norco
  • Senokot
  • Colace
  • Cipro
Patient was hospitalized.

Rhabdomyolysis
Adverse event was reported on Apr 05, 2013 by a Male taking Daptomycin (Dosage: N/A) . Location: US , 57 years of age, Patient felt the following Daptomycin side effects: rhabdomyolysis.


on Mar 13, 2013 Female from US , 74 years of age, weighting 106.0 lb, was diagnosed with and was treated with Daptomycin. . Daptomycin dosage: N/A.

Eosinophilic Pneumonia
on Jan 28, 2013 Male from US , 63 years of age, weighting 194.0 lb, was diagnosed with and was treated with Daptomycin. Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: eosinophilic pneumonia. Daptomycin dosage: N/A. Patient was hospitalized.

Pyrexia, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Patient was taking Daptomycin. Patient felt the following Daptomycin side effects: pyrexia, aspartate aminotransferase increased, alanine aminotransferase increased on Jan 16, 2013 from US Additional patient health information: Female , 48 years of age, . Daptomycin dosage: N/A.

Urticaria
Adverse event was reported on Jan 02, 2013 by a Male taking Daptomycin (Dosage: 500 Mg Ud Iv) was diagnosed with and. Location: US , 79 years of age, weighting 251.3 lb, After Daptomycin was administered, patient encountered several Daptomycin side effects: urticaria.

Hyperglycaemia, Pyrexia, Chills, Eosinophilia, Pulmonary Eosinophilia, Red Blood Cell Sedimentation Rate Increased
on Dec 24, 2012 Male from US , 70 years of age, weighting 173.7 lb, was diagnosed with and was treated with Daptomycin. Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: hyperglycaemia, pyrexia, chills, eosinophilia, pulmonary eosinophilia, red blood cell sedimentation rate increased. Daptomycin dosage: 500 Mg Every Day Iv. Patient was hospitalized.

Eosinophilic Pneumonia
on Dec 18, 2012 Male from US , 69 years of age, weighting 130.5 lb, was diagnosed with and was treated with Daptomycin. Patient felt the following Daptomycin side effects: eosinophilic pneumonia. Daptomycin dosage: N/A.

Dyspnoea, Cough, Hypoxia
Patient was taking Daptomycin. After Daptomycin was administered, patient encountered several Daptomycin side effects: dyspnoea, cough, hypoxia on Dec 18, 2012 from US Additional patient health information: Male , 44 years of age, weighting 198.4 lb, was diagnosed with and. Daptomycin dosage: 540 Mg Q24h Iv (042).

Renal Failure Acute, Dehydration, No Therapeutic Response, Renal Tubular Necrosis
Adverse event was reported on Dec 13, 2012 by a Male taking Daptomycin (Dosage: 750 Mg Every Day Iv) was diagnosed with and. Location: US , 66 years of age, weighting 282.6 lb, Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: renal failure acute, dehydration, no therapeutic response, renal tubular necrosis. Patient was hospitalized.

Hypersensitivity, Pneumonitis
on Dec 05, 2012 Male from US , 68 years of age, weighting 186.3 lb, was diagnosed with and was treated with Daptomycin. Patient felt the following Daptomycin side effects: hypersensitivity, pneumonitis. Daptomycin dosage: 500 Mg Q24h Iv (042).

Hypotension, Fluid Overload, Adrenal Insufficiency, Urinary Tract Infection, Candidiasis, Supraventricular Tachycardia, Eosinophilic Pneumonia, Nausea, Retching
on Nov 21, 2012 Female from US , 62 years of age, weighting 195.3 lb, was treated with Daptomycin. After Daptomycin was administered, patient encountered several Daptomycin side effects: hypotension, fluid overload, adrenal insufficiency, urinary tract infection, candidiasis, supraventricular tachycardia, eosinophilic pneumonia, nausea, retching. Daptomycin dosage: 500 Mg Every Day Iv. Patient was hospitalized.

Myalgia, Blood Creatine Phosphokinase Increased, Overdose, Hepatic Function Abnormal, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Patient was taking Daptomycin. Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: myalgia, blood creatine phosphokinase increased, overdose, hepatic function abnormal, aspartate aminotransferase increased, alanine aminotransferase increased on Nov 09, 2012 from JP Additional patient health information: Male , 38 years of age, weighting 220.5 lb, was diagnosed with and. Daptomycin dosage: N/A.
Associated medications used: Patient was hospitalized.

Eosinophilic Pneumonia
Adverse event was reported on Nov 09, 2012 by a Female taking Daptomycin (Dosage: 500 Mg Q24h Iv) was diagnosed with and. Location: US , 59 years of age, weighting 211.4 lb, Patient felt the following Daptomycin side effects: eosinophilic pneumonia.
Multiple prescriptions taken:
  • Calcium Carbonate
  • Lantus
  • Victoza
  • Metformin
  • Levothyroxine
  • Lisinopril
  • Potassium Chloride
  • Vitamin D3
Patient was hospitalized.

Sepsis, Staphylococcus Test Positive, Movement Disorder, Eosinophilic Pneumonia
on Oct 26, 2012 Male from US , 70 years of age, weighting 180.8 lb, was diagnosed with and was treated with Daptomycin. After Daptomycin was administered, patient encountered several Daptomycin side effects: sepsis, staphylococcus test positive, movement disorder, eosinophilic pneumonia. Daptomycin dosage: N/A.
Multiple concurrent drugs taken:

Endocarditis, Medical Device Complication, Oedema, Oedema Peripheral, Wheezing, Acute Respiratory Failure, Dizziness, Syncope, Pulmonary Oedema
on Oct 19, 2012 Male from US , 91 years of age, weighting 165.3 lb, was diagnosed with and was treated with Daptomycin. Directly after, patient experienced the unwanted or unexpected Daptomycin side effects: endocarditis, medical device complication, oedema, oedema peripheral, wheezing, acute respiratory failure, dizziness, syncope, pulmonary oedema. Daptomycin dosage: 8 Mg/kg Q24h Iv. Patient was hospitalized and became disabled.

Page 1 of 11 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Daptomycin

Find Out How to Take Daptomycin

Discuss Daptomycin Side Effects

Did You Have a Daptomycin Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Daptomycin for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

More About Daptomycin

Side Effects reported to FDA: 258

Daptomycin safety alerts: 2013 2010 2008

Reported deaths: 8

Reported hospitalizations: 117

Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia

[Posted 07/29/2010]

AUDIENCE: Infectious Disease, Pulmonology

ISSUE:  FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug indicated for use in treatment of serious skin infections and bloodstream infections. Eosinophilic pneumonia is a rare but serious condition where a type of white blood cell (eosinophil) fills the lungs. Symptoms of eosinophilic pneumonia include fever, cough, shortness of breath, and difficulty breathing. Eosinophilic pneumonia may lead to progressive respiratory failure and is potentially fatal if not quickly recognized and appropriately managed. 

BACKGROUND: FDA has reviewed published case reports of Cubicin-associated eosinophilic pneumonia and conducted a review of post-marketing adverse event reports from the FDA's Adverse Event Reporting System. FDA's review identified 7 cases of eosinophilic pneumonia between 2004 and 2010 that were most likely associated with Cubicin. Based on these reviews, FDA determined that eosinophilic pneumonia can be associated with Cubicin use and requested that the manufacturer of Cubicin include this information in the Warnings and Precautions and Adverse Reactions, Post-Marketing Experience sections of the drug label.

RECOMMENDATION: Healthcare professionals should closely monitor patients being treated with Cubicin for eosinophilic pneumonia. Patients receiving Cubicin should immediately contact their healthcare professional if they develop a new or worsening fever, cough, shortness of breath, or difficulty breathing.

Additional information for Healthcare Professionals, Information for Patients, a Data Summary, and References are provided in the Drug Safety Communication at the link below.

[07/29/2010 - Drug Safety Communication - FDA]
[Jan 2010 - Cubicin (daptomycin) Prescribing Information - Cubist Pharmaceuticals]

Latest Daptomycin clinical trials

Related health facts